Ubs Group Ag Clear Point Neuro, Inc. Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
A detailed history of Ubs Group Ag transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 29,047 shares of CLPT stock, worth $325,616. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,047
Previous 52,021
44.16%
Holding current value
$325,616
Previous $353,000
55.81%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding CLPT
# of Institutions
90Shares Held
7.04MCall Options Held
35KPut Options Held
22.8K-
Vanguard Group Inc Valley Forge, PA1.22MShares$13.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny465KShares$5.22 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA463KShares$5.19 Million0.49% of portfolio
-
Taylor Frigon Capital Management LLC425KShares$4.76 Million1.1% of portfolio
-
Cm Management, LLC375KShares$4.2 Million1.88% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $275M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...